Description: Rabbit polyclonal antibody to RPS9 Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the center region of human RPS9. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography. Clonality: Polyclonal Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. Dilution: WB (1/500 - 1/1000), IH (1/50 - 1/100), IF/IC (1/50 - 1/200), FC (1/100 - 1/200) Gene Symbol: RPS9 Alternative Names: 40S ribosomal protein S9Entrez Gene (Human): 6203Entrez Gene (Mouse) : 76846Entrez Gene (Rat) : 100909466; 81772SwissProt (Human): P46781SwissProt (Mouse) : Q6ZWN5SwissProt (Rat) : P29314Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of RPS9 expression in Jurkat (A), HEK293 (B), HeLa (C), NIH3T3 (D) whole cell lysates.
-
Immunohistochemical analysis of RPS9 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
-
Immunofluorescent analysis of RPS9 staining in Jurkat cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
The flavonoid apigenin downregulates CDK1 by directly targeting ribosomal protein S9
Tagging of functional ribosomes in living cells by HaloTag® technology
Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities